The cohort of analyzed papillary carcinomas was also small in our study, but evidence for a possible prognostic role of 3p deletions but not of VHL mutations for both relapse-free survival and cancer specific death arises from this analysis (Figure 4). The gene discussed is VHL; the disease is thyroid gland papillary carcinoma.